We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
96 hedge funds and large institutions have $736M invested in Rocket Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
340% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 5
227% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 15
19% more funds holding
Funds holding: 81 → 96 (+15)
2.52% more ownership
Funds ownership: 95.04% → 97.57% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $751M → $736M (-$15M)
85% less call options, than puts
Call options by funds: $323K | Put options by funds: $2.15M
Holders
96
Holders Change
+15
Holders Change %
+18.52%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
22
Increased
49
Reduced
15
Closed
5
Calls
$323K
Puts
$2.15M
Net Calls
-$1.82M
Net Calls Change
-$1.97M
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$26.5M |
| 2 |
DM
Deerfield Management
New York
|
+$15M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
+$13.7M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$9.84M |
| 5 |
RI
RTW Investments
New York
|
+$9.6M |
